- A pilot study led by Friends of Cancer Research (Friends) investigated how real world evidence (RWE) compares to the results from randomised clinical trials (RCTs) (for advanced non-small cell lung cancer).
- The study showed consistency between RWE and RCTs, emphasising their potential for supporting clinical decision-making
- “RWE is an important tool for continued learning about treatment outcomes over time,” – Dr. Jeff Allen, President & CEO of Friends
Click here to see the source article
SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.